Global Vice President, M&A Operations, Divestitures and IDV BD, Johnson & Johnson
Dr. De Backer has been a strategic advisor, scientist, business leader, deal maker and corporate investor at the world’s largest healthcare company -Johnson & Johnson- for more than two decades. Her deep expertise in forging partnerships with leading researchers and executives has led to new breakthroughs in medicine (Olysio®, Odefsey®, Symtuza®, and Juluca®). She works across an extensive external network of pharmaceutical, biotech, academic, VC, NGO and government partners globally. In her current role she leads M&A Operations and Divestitures for the global Pharmaceuticals Group of J&J (Janssen) and is head business development for the Infectious Diseases & Vaccines therapeutic area. She is a member of the Board of Directors of Gladstone Foundation and of EcoHealth Alliance. She holds an MBA from Erasmus University Rotterdam, a PhD in Biotechnology and Master in Engineering from the University of Ghent, and a MSc in Molecular Biology from the University of Brussels.